BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29921210)

  • 21. Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey.
    Stewart D; Rouf A; Snaith A; Elliott K; Helms PJ; McLay JS
    Br J Clin Pharmacol; 2007 Jul; 64(1):90-5. PubMed ID: 17324238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paracetamol prescribing in primary care: too little and too much?
    Kazouini A; Mohammed BS; Simpson CR; Helms PJ; McLay JS
    Br J Clin Pharmacol; 2011 Sep; 72(3):500-4. PubMed ID: 21592184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs.
    Smithburger PL; Buckley MS; Culver MA; Sokol S; Lat I; Handler SM; Kirisci L; Kane-Gill SL
    Crit Care Med; 2015 Aug; 43(8):1612-21. PubMed ID: 25855897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychotropic medication use in the child and adolescent psychiatry wards of a French hospital.
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Pharm World Sci; 2008 Oct; 30(5):600-4. PubMed ID: 18493863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
    O'Donnell CP; Stone RJ; Morley CJ
    Pediatrics; 2002 Nov; 110(5):e52. PubMed ID: 12415058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Off-label and unlicensed prescribing for children: have we made any progress?
    Waller DG
    Br J Clin Pharmacol; 2007 Jul; 64(1):1-2. PubMed ID: 17577389
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical symptoms and 'off-label' prescribing in children with asthma.
    McCowan C; Hoskins G; Neville RG
    Br J Gen Pract; 2007 Mar; 57(536):220-2. PubMed ID: 17359609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
    't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
    Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil.
    Santos DB; Clavenna A; Bonati M; Coelho HL
    Eur J Clin Pharmacol; 2008 Nov; 64(11):1111-8. PubMed ID: 18685837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.
    Gavrilov V; Lifshitz M; Levy J; Gorodischer R
    Isr Med Assoc J; 2000 Aug; 2(8):595-7. PubMed ID: 10979352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prescription of drugs not appropriate for children in a Pediatric Intensive Care Unit].
    Carvalho PR; Carvalho CG; Alievi PT; Martinbiancho J; Trotta EA
    J Pediatr (Rio J); 2003; 79(5):397-402. PubMed ID: 14557839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unlicensed and off-label drug use in a Swiss paediatric university hospital.
    Di Paolo ER; Stoetter H; Cotting J; Frey P; Gehri M; Beck-Popovic M; Tolsa JF; Fanconi S; Pannatier A
    Swiss Med Wkly; 2006 Apr; 136(13-14):218-22. PubMed ID: 16633971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital.
    't Jong GW; Vulto AG; de Hoog M; Schimmel KJ; Tibboel D; van den Anker JN
    Pediatrics; 2001 Nov; 108(5):1089-93. PubMed ID: 11694685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription of off-label and unlicensed drugs for preterm infants in a neonatal intensive care unit.
    Vieira VC; Costa RS; Lima RCG; Queiroz DB; Medeiros DS
    Rev Bras Ter Intensiva; 2021; 33(2):266-275. PubMed ID: 34231807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Off-label use of drugs in Italy: a prospective, observational and multicentre study.
    Pandolfini C; Impicciatore P; Provasi D; Rocchi F; Campi R; Bonati M;
    Acta Paediatr; 2002; 91(3):339-47. PubMed ID: 12022310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levetiracetam prescription profile in children younger than 4 years treated at a tertiary care hospital in Chile.
    Kyonen M; Acuña L; Ramos B; Gutiérrez J; Barría RM
    Arch Argent Pediatr; 2024 Aug; 122(4):e202310233. PubMed ID: 38457309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Safety of Drug Therapy in Children.
    Wimmer S; Neubert A; Rascher W
    Dtsch Arztebl Int; 2015 Nov; 112(46):781-7. PubMed ID: 26806565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unlicensed and off label prescription of drugs to children: population based cohort study.
    'T Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Stricker BH
    BMJ; 2002 Jun; 324(7349):1313-4. PubMed ID: 12039827
    [No Abstract]   [Full Text] [Related]  

  • 39. Ten common questions (and their answers) about off-label drug use.
    Wittich CM; Burkle CM; Lanier WL
    Mayo Clin Proc; 2012 Oct; 87(10):982-90. PubMed ID: 22877654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Off-label drug use in human immunodeficiency virus disease.
    Brosgart CL; Mitchell T; Charlebois E; Coleman R; Mehalko S; Young J; Abrams DI
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):56-62. PubMed ID: 8624761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.